DGKZ Rekombinanter Antikörper
DGKZ Rekombinant Antikörper für WB, IHC, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
241444A2
Kat-Nr. : 84830-5-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84830-5-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA DGKZ und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | DGKZ fusion protein Ag37336 |
| Vollständiger Name | diacylglycerol kinase, zeta 104kDa |
| Berechnetes Molekulargewicht | 104kDa,928aa |
| Beobachtetes Molekulargewicht | 104-124 kDa |
| GenBank-Zugangsnummer | NM_001199267.1 |
| Gene symbol | DGKZ |
| Gene ID (NCBI) | 8525 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Diacylglycerol kinase zeta (DGKZ), also known as DAGK5, DAGK6, DGK-ZETA, hDGKzeta, belongs to the diacylglycerol kinase (DGK) family which catalyzes diacylglycerol (DAG) into phosphatidic acid (PA). DGKZ is a novel promoter of metastasis and that it could be a potential prognostic indicator in patients with triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGFbetaR2(PMID: 35115500). Downregulation of DGKZ suppresses tumorigenesis and progression of cervical cancer by facilitating cell apoptosis and cell cycle arrest(PMID: 33926342).











